Multibacillary
|
concentration of lipid
|
5.5E-04 |
−2.2 |
C1QA,CES1,CYBB,CYP4F2,FABP5,JUN,P2RY13,PDK4,S100A12,S100A8,S100A9,STARD10
|
12 |
concentration of fatty acid
|
1.0E-02 |
−2.2 |
CES1,CYP4F2,P2RY13,PDK4,STARD10
|
5 |
concentration of triacylglycerol
|
5.2E-04 |
−0.9 |
C1QA,CES1,CYBB,FABP5,JUN,PDK4,STARD10
|
7 |
concentration of cholesterol
|
1.8E-03 |
−0.7 |
CES1,CYBB,FABP5,JUN,P2RY13,STARD10
|
6 |
fatty acid metabolism
|
7.1E-03 |
0.5 |
CES1,CYP4F2,FABP5,KLF5,PDK4,S100A12,S100A8,S100A9
|
8 |
efflux of cholesterol
|
1.1E-03 |
0.9 |
CES1,S100A12,S100A8,S100A9
|
4 |
transport of lipid
|
3.6E-03 |
1.5 |
CES1,FABP5,S100A12,S100A8,S100A9
|
5 |
Paucibacillary
|
transport of lipid
|
2.9E-02 |
−0.1 |
CD14,CES1,FABP3,ITGB3
|
4 |
catabolism of lipid
|
1.7E-02 |
|
AKR1C3,CES1,PLA2G7
|
3 |
binding of lipopolysaccharide
|
3.0E-03 |
|
BPI,CD14
|
2 |
transmission of lipid
|
5.4E-03 |
|
CD14,CES1
|
2 |
hydrolysis of triacylglycerol
|
1.2E-02 |
|
FABP3,PLA2G7
|
2 |
oxidation of palmitic acid
|
2.2E-02 |
|
FABP3,PDK4
|
2 |
quantity of diacylglycerol
|
2.5E-02 |
|
CES1,PDK4
|
2 |
transport of fatty acid
|
4.0E-02 |
|
CES1,FABP3
|
2 |
Resilient
|
concentration of lipid
|
3.5E-03 |
−1.9 |
CYBB,FABP3,HNF4A,OLR1,P2RY13,PTGS2,S100A9,STARD10
|
8 |
concentration of cholesterol
|
1.6E-04 |
−1.7 |
CYBB,HNF4A,OLR1,P2RY13,PTGS2,STARD10
|
6 |
synthesis of eicosanoid
|
3.2E-03 |
−1.2 |
HNF4A,KLF5,OLR1,PTGS2
|
4 |
fatty acid metabolism
|
1.9E-03 |
−1.0 |
ACSL6,FABP3,HNF4A,KLF5,OLR1,PTGS2,S100A9
|
7 |
concentration of fatty acid
|
1.5E-03 |
−0.5 |
FABP3,OLR1,P2RY13,PTGS2,STARD10
|
5 |
uptake of lipid
|
1.1E-03 |
0.0 |
A2M,FABP3,OLR1,THBS1
|
4 |
uptake of long chain fatty acid
|
3.1E-05 |
|
FABP3,OLR1,THBS1
|
3 |
homeostasis of phospholipid
|
2.7E-04 |
|
FABP3,HNF4A
|
2 |
uptake of palmitic acid
|
9.8E-04 |
|
FABP3,OLR1
|
2 |
homeostasis of lipid
|
1.4E-03 |
|
FABP3,HNF4A,PTGS2,STARD10
|
4 |
transport of long chain fatty acid
|
2.5E-03 |
|
ACSL6,FABP3
|
2 |